Correlation Of Peripheral Blood Involvement Measured By Four-Color Flow Cytometry And The Achievement Of Molecular Response In Mantle Cell Lymphoma Treated Within The Prospectively Randomized Intergroup Trials Of The European Mcl Network

Two prospectively randomized intergroup trials of the European MCL Network investigating the impact of different combined immuno-chemotherapy protocols for patients with stage II–IV mantle cell lymphoma (MCL) >< 65 yrs followed by autologous stem cell transplantation (PBSCT) for patients <65 yrs and a rituximab or interferone maintenance treatment for patients >65 yrs are currently performed.